Trial reportBJA open2026
A perioperative medicine platform trial (PROMPT) evaluating interventions to reduce the risk of infection and other major complications after surgery: rationale and design.
Trial report in BJA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07186634 (Domain-Specific Appendix), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Domain-Specific Appendix: OXYGEN
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Platform trials are an extremely powerful, cost-effective innovation in clinical trial design and evidence-to-practice translation. As questions are answered progressively, additional new interventions, within the same or new domains, are substituted into the platform. This design is ideal for evaluation of interventions aiming to reduce surgical site infection, which remains the most common serious complication after surgery. Objective: To efficiently identify effective, ineffective, or harmful treatments to reduce the incidence of perioperative infections and other major complications after surgery. Study design: Perioperative medicine adaptive platform trial (PROMPT) is a multicentre, Bayesian adaptive platform trial designed to reach conclusions regarding superiority, efficacy, equivalence, inferiority, harm, or futility. Modules within the protocol include the master protocol, multiple domain-specific appendices, and a statistical appendix. Study population: Adult patients undergoing a broad range of surgical procedures in participating hospitals. Interventions: Specific interventions under study will be described in domain-specific appendices. The first intervention under study is liberal inspired oxygen concentrations during surgery. Outcomes: The primary outcome is the incidence of surgical site infection up to 30 days after index surgery; this will apply to all domains unless otherwise specified in a domain-specific appendix. Secondary outcomes include other health care-associated infections and major postoperative complications up to 30 days after surgery, quality of recovery (QoR-15) at 3 and 30 days after surgery, and days alive and at home up to 30 days after surgery (DAH Conclusions: PROMPT is designed to efficiently evaluate interventions aiming to reduce surgical site infection and other major complications after surgery. Clinical trial registration: NCT07186634. Protocol version number and date: 1.1, December 4, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.